Catalyst Wire Dossier Catalyst Wire Dossier

Naltrexone SR/Bupropion SR (combination therapy)

naltrexone sustained-release / bupropion sustained-release · Orexigen Therapeutics, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Naltrexone SR/Bupropion SR (combination therapy), covering 2014-11-21 to 2014-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program [Phase 3]

See pricing